Determination of Specific CD4 and CD8 T Cell Epitopes after AAV2- and AAV8-hF.IX Gene Therapy

This publication has 34 references indexed in Scilit:

• Genetic analysis of the antibody response to AAV2 and factor IX
  Molecular Therapy, 2005
• UNDERSTANDING PRESENTATION OF VIRAL ANTIGENS TO CD8⁺T CELLS IN VIVO: The Key to Rational Vaccine Design
  Annual Review of Immunology, 2005
• Mapping of genes that control the antibody response to human factor IX in mice
  Blood, 2005
• Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
  Gene Therapy, 2004
• 1002. Immune Responses to AAV and to Factor IX in a Phase I Study of AAV-Mediated, Liver-Directed Gene Transfer for Hemophilia B
  Molecular Therapy, 2004
• Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice
  Blood, 2004
• Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy
  Human Gene Therapy, 2002
• The Adenovirus Capsid Protein Hexon Contains a Highly Conserved Human CD4⁺T-Cell Epitope
  Human Gene Therapy, 2002
• Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver
  Journal of Virology, 2002
• Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9
  Molecular Therapy, 2001